Claire Gaunt

1.7k total citations
15 papers, 382 citations indexed

About

Claire Gaunt is a scholar working on Cancer Research, Oncology and Surgery. According to data from OpenAlex, Claire Gaunt has authored 15 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Oncology and 4 papers in Surgery. Recurrent topics in Claire Gaunt's work include Breast Cancer Treatment Studies (6 papers), Breast Lesions and Carcinomas (4 papers) and Neutropenia and Cancer Infections (3 papers). Claire Gaunt is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Breast Lesions and Carcinomas (4 papers) and Neutropenia and Cancer Infections (3 papers). Claire Gaunt collaborates with scholars based in United Kingdom. Claire Gaunt's co-authors include Neil Steven, Lucinda Billingham, Michael Cullen, Simon Gollins, Mark Bower, Indrajit Fernando, Daniel Rea, Robert Huddart, Peter Simmonds and Andrew Stanley and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Claire Gaunt

14 papers receiving 374 citations

Peers

Claire Gaunt

ONCOL

EPIDE

GENET

Francisca M. Marti United Kingdom

G. Fleischhack Germany

Colombe Saillard France

W. Mark Roberts United States

Larissa Henze Germany

H.-J. Laws Germany

Øystein Wendelbo Norway

Lotte Boxhoorn Netherlands

Johnny McHugh Ireland

Douglas W. Huestis United States

Francisca M. Marti United Kingdom

Claire Gaunt

307 ×1.0

ONCOL

131 ×1.1

76 ×0.9

EPIDE

73 ×1.1

68 ×1.1

GENET

Citations per year, relative to Claire Gaunt Claire Gaunt (= 1×) peers Francisca M. Marti

Countries citing papers authored by Claire Gaunt

Since Specialization

Citations

This map shows the geographic impact of Claire Gaunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Gaunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Gaunt more than expected).

Fields of papers citing papers by Claire Gaunt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Gaunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Gaunt. The network helps show where Claire Gaunt may publish in the future.

Co-authorship network of co-authors of Claire Gaunt

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Gaunt. A scholar is included among the top collaborators of Claire Gaunt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Gaunt. Claire Gaunt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Mehanna, Hisham, Piers Gaunt, Martin Förster, et al.. (2025). 1317O Results from CompARE phase III RCT: Neoadjuvant durvalumab plus chemoradiotherapy (CRT) followed by adjuvant durvalumab immunotherapy (IO) vs CRT alone in intermediate and high-risk oropharyngeal cancer (OPC). Annals of Oncology. 36. S768–S768.

Patel, Amit, Kristian Brock, Daniel Slade, et al.. (2024). Implementing the time-to-event continual reassessment method in the presence of partial orders in a phase I head and neck cancer trial. BMC Medical Research Methodology. 24(1). 11–11. 2 indexed citations

McIntosh, Stuart, Charlotte E. Coles, David Dodwell, et al.. (2023). SMALL: Open surgery versus minimally invasive vacuum-assisted excision for small screen-detected breast cancer—A UK phase III randomised multi-centre trial.. Journal of Clinical Oncology. 41(16_suppl). TPS625–TPS625. 2 indexed citations

McIntosh, Stuart, Charlotte E. Coles, David Dodwell, et al.. (2023). Abstract OT3-20-02: SMALL: Open Surgery versus Minimally invasive vacuum-Assisted excision for smaLL screen-detected breast cancer – a UK phase III randomised multi-centre trial. Cancer Research. 83(5_Supplement). OT3–20. 1 indexed citations

McIntosh, Stuart, Charlotte E. Coles, David Dodwell, et al.. (2022). SMALL: Open surgery versus minimally invasive vacuum-assisted excision for small screen-detected breast cancers.. Journal of Clinical Oncology. 40(16_suppl). TPS614–TPS614. 1 indexed citations

Pascoe, Jennifer, Aimee Jackson, Charlotte Gaskell, et al.. (2021). Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH). BMC Cancer. 21(1). 800–800. 18 indexed citations

Mehanna, Hisham, Mehmet Şen, John Chester, et al.. (2017). Phase III randomised controlled trial (RCT) comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer (CompARE).. Journal of Clinical Oncology. 35(15_suppl). TPS6091–TPS6091. 10 indexed citations

Thomas, James, AM Hanby, Sarah E. Pinder, et al.. (2017). Abstract P3-17-06: LORIS trial of active monitoring for DCIS: How does the online pathology eligibility review process work?. Cancer Research. 77(4_Supplement). P3–17. 3 indexed citations

Gaunt, Claire & Tom Woolley. (2014). Management of haemorrhage in major trauma. Continuing Education in Anaesthesia Critical Care & Pain. 14(6). 251–255. 8 indexed citations

10.

Bliss, Judith M., Peter Canney, G. Velikova, et al.. (2010). Abstract P5-10-07: TACT2 Randomised Adjuvant Trial in Early Breast Cancer (EBC): Tolerability and Toxicity of Standard 3 Weekly Epirubicin (E) Versus Accelerated Epirubicin (aE) Followed by Capecitabine (X) or CMF in 129 UK Hospitals (CRUK/05/019). Cancer Research. 70(24_Supplement). P5–10. 1 indexed citations

11.

Cameron, David, Peter Barrett‐Lee, Galina Velikova, et al.. (2010). Abstract P5-10-06: TACT2 Randomised Adjuvant Trial in Early Breast Cancer (EBC): Tolerability and Toxicity of Standard 3 Weekly Epirubicin (E) Versus Accelerated Epirubicin (aE) in 129 UK Hospitals (4391 Patients) (CRUK/05/019). Cancer Research. 70(24_Supplement). P5–10. 2 indexed citations

12.

Gaunt, Claire, et al.. (2009). British Military Use of Morphine: A Historical Review. Journal of the Royal Army Medical Corps. 155(1). 46–49. 9 indexed citations

13.

Cullen, Michael, Lucinda Billingham, Claire Gaunt, & Neil Steven. (2007). Rational Selection of Patients for Antibacterial Prophylaxis After Chemotherapy. Journal of Clinical Oncology. 25(30). 4821–4828. 37 indexed citations

14.

Cullen, Michael, Neil Steven, Lucinda Billingham, et al.. (2005). Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas. New England Journal of Medicine. 353(10). 988–998. 275 indexed citations

15.

Billingham, Lucinda, et al.. (2005). Management of febrile neutropenia in the United Kingdom: time for a national trial?. British Journal of Cancer. 93(12). 1324–1328. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact